Next-Gen Emergency Glucagon: Xeris to the Rescue? | Type one diabetes, Diabetes supplies, Diabetes
Coming Soon: Generic Glucagon Rescue
Zegalogue: A New Easy-to-Use Diabetes Rescue Glucagon
Xeris | diaTribe
S-1/A
Xeris' glucagon injection Gvoke gains heat with HypoPen auto-injector launch | FiercePharma
Biodel, Latitude, and Xeris Seek to Improve Glucagon | diaTribe
Xeris Pharmaceuticals Submits New Drug Application for Glucagon Rescue Pen | dLife
FDA OKs Ready-To-Use Gvoke Glucagon By Xeris
Zegalogue: A New Easy-to-Use Diabetes Rescue Glucagon
Xeris gets $41M for shelf-stable glucagon pen
Xeris Pharmaceuticals Is An Attractive Buy Opportunity In 2018 (NASDAQ:XERS) | Seeking Alpha
xeriscanaccordaug2018fin
In the Know with GVOKE: Conversations about Severe Low Blood Sugar and New Treatment Options – Greater New York City Chapter
Ready-to-use glucagon rescue pen - Type 1 and LADA - TuDiabetes Forum
FDA Approves Potentially Life Saving GVOKE: Xeris' Ready-to-Use Glucagon | diaTribe
How To Use Gvoke HypoPen® (glucagon injection) & Gvoke® PFS (glucagon injection)
Xeris Pharma Announces FDA to Review NDA for Its Ready-to-Use Glucagon Rescue Pen | dLife
Xeris scores first FDA nod with shelf-stable glucagon injector, syringe | FiercePharma
Xeris Pharmaceuticals Aims For $75 Million IPO (NASDAQ:XERS) | Seeking Alpha
Xeris: Preparing For The Gvoke PDUFA (NASDAQ:XERS) | Seeking Alpha
Two New Glucagon Formulations Await FDA Approval in 2019 — Healthy Living Medical Supply
New Glucagon Rescue Pen: Gvoke HypoPen - Diabetes Self-Management
Xeris Raises $55M for Glucagon Rescue Pen | BioSpace
Ready-to-Use Glucagon Rescue Pen Under FDA Review for Severe Hypoglycemia Tx - MPR
Ready-To-Use Glucagon Rescue Pen
